Who at a manufacturing company should track these rules?

Plant Compliance Lead, ESG officer, or industrial-automation GC is typically the role accountable for manufacturing-AI compliance. AIGI is designed to put primary-source updates in front of this role daily.

How many manufacturing AI items does AIGI track?

AIGI currently tracks 91 primary-source items where manufacturing appears as an affected industry, spanning 8+ jurisdictions. The corpus is updated continuously.

Which jurisdictions are most active on manufacturing AI?

Activity varies by sub-sector. AIGI's coverage map shows per-jurisdiction depth, and each item links to its primary authority source. See /coverage for the live distribution.

Where do AIGI's manufacturing citations come from?

Every item on this page links to its primary government, regulator, or research source. AIGI does not paraphrase secondary commentary — our citation methodology is documented at /how-we-cite.

Industry · Industrial AI, machinery safety, and supply-chain due diligence

AI Compliance for Manufacturing

AI in manufacturing touches the EU AI Act's safety-component provisions, OSHA and equivalent worker-safety standards for AI-controlled machinery, supply-chain-due-diligence laws including AI-driven supplier scoring, and AI in industrial IoT. AIGI tracks every primary-source AI rule for industrial manufacturers and supply chains. As of the most recent update, AIGI tracks 91 primary-source items affecting manufacturing.

Who tracks this?

Typically: Plant Compliance Lead, ESG officer, or industrial-automation GC. AIGI is built to put primary-source AI updates affecting manufacturing in front of this role daily — with citation chains, status timelines, and obligation mapping.

Coverage at a glance

Items tracked: 91
Jurisdictions: 8
Last update: 4/13/2026

Most active jurisdictions for manufacturing AI

Recent manufacturing AI activity

CA policy paper introduced 4/13/2026

[EFF] The Dangers of California’s Legislation to Censor 3D Printing

California's AB 2047 mandates censorware on 3D printers, criminalizes open-source alternatives, and risks consumer harms like surveillance and platform lock-in, potentially stifling innovation and choice.

Authority: Electronic Frontier Foundation
NY policy paper introduced 4/16/2026

[EFF] Stop New York's Attack on 3D Printing

New York's proposed budget includes provisions for mandatory print-blocking censorware on 3D printers and felony charges for possessing/sharing certain design files.

Authority: Electronic Frontier Foundation
FR agency report enforcement 5/18/2026

[CNIL] Rapport annuel : le bilan et les actions marquantes de la CNIL en 2025

The CNIL's 2025 annual report details a record year of GDPR enforcement with €487M in fines, a surge in complaints and data breaches, and active preparation for the EU AI Act.

Authority: CNIL
US rulemaking notice comment period 4/29/2026

[FDA] AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information

The FDA is requesting information on an AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program to gather public input by May 29, 2026.

Authority: Food and Drug Administration
EU agency report 5/7/2026

[EU Digital Strategy] Info session - Call for proposals Digital solutions for regulatory compliance through data

The EU AI Office is holding an info session for a call for proposals under the Digital Europe Programme focused on developing AI-powered digital solutions for regulatory compliance, with a submission deadline of October 1, 2026.

Authority: European AI Office
US policy paper 5/20/2026

[RAND] Expert InsightsMay 20, 2026Building Resilience Against Artificial Intelligence–Enabled Biological Threats: Conference Proceedings from a RAND and Helena WorkshopThese conference proceedings summarize the outputs from a workshop in which participants developed broadly applicable mitigation strategies for possible threat scenarios at the intersection of artificial intelligence and biology.

These conference proceedings summarize mitigation strategies developed by experts at a RAND and Helena workshop to build resilience against AI-enabled biological threats through technical, policy, operational, and organizational interventions.

Authority: RAND Corporation
EU rulemaking notice comment period 5/19/2026

[EU Digital Strategy] Survey on the EU legal framework for health data and data driven health technologies

The European Commission launched a survey to gather real-world experience on health data access, reuse, and compliance with EU rules for data-driven digital health technologies, including AI, by May 22, 2026.

Authority: European AI Office
US rulemaking notice comment period 4/29/2026

[FDA] AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information

The FDA is requesting information for a pilot program on AI-enabled optimization in early-phase clinical trials to inform future regulatory approaches.

Authority: Food and Drug Administration
NY legislation committee 3/10/2026

[NY Legislature] S9408 (2025-2026): Relates to a prohibition on chatbot toys

New York bill S9408 proposes to prohibit the manufacture, exchange, distribution, and sale of chatbot toys within the state.

Authority: New York Legislature
NY legislation committee 4/24/2026

[NY Legislature] A11144 (2025-2026): Relates to a prohibition on chatbot toys

New York Assembly Bill A11144 proposes to prohibit the manufacture, exchange, distribution, and sale of chatbot toys within the state.

Authority: New York Legislature
EU agency report effective 5/7/2026

[EU Digital Strategy] EU agrees to simplify AI rules to boost innovation and ban ‘nudification' apps to protect citizens

The EU reached an agreement to simplify AI Act rules for innovation and protect citizens by banning 'nudification' apps, setting implementation timelines for high-risk AI systems.

Authority: European AI Office
EU agency report enacted 5/7/2026

[EU Digital Strategy] EU agrees to simplify AI rules to boost innovation and ban ‘nudification' apps to protect citizens

The EU has agreed to simplify AI Act rules for innovation and protect citizens by banning 'nudification' apps, setting clear implementation deadlines for high-risk AI systems.

Authority: European AI Office

+ 79 more — start trial for full access.

Frequently asked questions

Which AI laws apply to manufacturing?: AI in manufacturing touches the EU AI Act's safety-component provisions, OSHA and equivalent worker-safety standards for AI-controlled machinery, supply-chain-due-diligence laws including AI-driven supplier scoring, and AI in industrial IoT. AIGI tracks every primary-source AI rule for industrial manufacturers and supply chains.
Who at a manufacturing company should track these rules?: Plant Compliance Lead, ESG officer, or industrial-automation GC is typically the role accountable for manufacturing-AI compliance. AIGI is designed to put primary-source updates in front of this role daily.
How many manufacturing AI items does AIGI track?: AIGI currently tracks 91 primary-source items where manufacturing appears as an affected industry, spanning 8+ jurisdictions. The corpus is updated continuously.
Which jurisdictions are most active on manufacturing AI?: Activity varies by sub-sector. AIGI's coverage map shows per-jurisdiction depth, and each item links to its primary authority source. See /coverage for the live distribution.
Where do AIGI's manufacturing citations come from?: Every item on this page links to its primary government, regulator, or research source. AIGI does not paraphrase secondary commentary — our citation methodology is documented at /how-we-cite.

Stay informed

Daily briefs on manufacturing AI compliance.

Start 14-day trial →

Important — about this brief

This brief is published by AIGI as a regulatory intelligence service. It contains general information about AI laws, regulations, enforcement actions, and policy signals across jurisdictions. It is not legal, compliance, audit, or risk-management advice; it does not establish an attorney-client, advisory, or fiduciary relationship; and it should not be relied upon as a substitute for professional counsel applied to specific facts and circumstances. Where the brief identifies “Issues for Review,” those are observations of questions a reader in a particular role might raise with their own legal, compliance, or risk function — not recommendations to act. AIGI expressly disclaims liability for actions taken or not taken in reliance on this brief. Subscribers in regulated industries should consult licensed professionals authorized to practice in their jurisdiction.

Full disclosures →